Corrigendum to “ApoptomiRs expression modulated by BCR–ABL is linked to CML progression and imatinib resistance” [Blood Cells Mol. Dis. 53 (1–2) (June–August 2014) 47–55]

Autor: Ferreira, A.F., Moura, L.G., Tojal, I., Ambrósio, L., Pinto-Simões, B., Hamerschlak, N., Calin, G.A., Ivan, C., Covas, D.T., Kashima, S., Castro, F.A.
Zdroj: In Blood Cells, Molecules and Diseases December 2015 55(4):420-420
Databáze: ScienceDirect